Both in Pharmaceuticals
Organon & vs Acadia Pharmaceuticals
Over the past year OGN returned +106.4% and ACAD returned −5.5%; their daily moves had a correlation of 0.02.
OGN +106.4% ACAD −5.5%Growth of $1, one year, split-adjusted
| Metric | OGN | ACAD |
|---|---|---|
| Price | $13.85 | $21.14 |
| Market cap | $3.64B | $3.64B |
| Today | 0.00% | +2.75% |
| 1 month | +0.8% | +7.1% |
| 6 months | +3.3% | −1.6% |
| Year to date | +93.2% | −20.9% |
| 1 year | +106.4% | −5.5% |
| Revenue growth (YoY) | −1.7% | +16.4% |
| Gross margin | 55.2% | 90.8% |
| Net margin | 10.4% | 10.2% |
| P/E (TTM) | 17.1× | 9.6× |
| Price / sales | 0.6× | 3.2× |
| Net cash | -$7.10B | $956.5M |
| Dividend yield | 0.58% | — |
| Volatility (60d) | 2.9% | 44.3% |
| Short % of float | 7.2% | 7.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).